Ideal or actual body weight to calculate CD34+cell doses for autologous hematopoietic stem cell transplantation?

被引:17
作者
Ali, MY [1 ]
Oyama, Y [1 ]
Monreal, J [1 ]
Winter, JN [1 ]
Tallman, MS [1 ]
Williams, SF [1 ]
Singhal, S [1 ]
Gordon, LI [1 ]
Mehta, J [1 ]
机构
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Hematol Oncol,Hematopoiet Stem Cell Transplan, Chicago, IL USA
关键词
autotransplantation; CD34+cells; engraftment; myeloid recovery; weight;
D O I
10.1038/sj.bmt.1703955
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The number of CD34 + cells infused influences the speed of hematologic recovery post-transplant. There are limited data on whether ideal (IBW) or actual (ABW) body weight should be used to calculate CD34 + cell dose. We compared the correlation between recovery to 0.5 x 10(9)/l neutrophils and the CD34 + cell dose based upon ABW as well as IBW in 87 patients autografted for cancer. ABW was greater than or equal to25% over IBW in 43% of patients. The median number of CD34 + cells administered was 3.6 x 10(6)/kg ABW and 4.2 x 10(6)/kg IBW. The time to neutrophil recovery was 8-15 days (median 10). There was a stronger inverse correlation between CD34 + cell dose/IBW and neutrophil recovery (r(2) = 0.308; P < 0.0001) than between CD34 + cell dose/ABW and neutrophil recovery (r(2) =0.267; P<0.0001). The median time to neutrophil recovery was comparable for those receiving greater than or equal to 2 x 10(6)/kg CD34+ cells/kg IBW as well as ABW (10 days) and those receiving greater than or equal to2x 10(6)/kg CD34+ cells/kg IBW but <2/kg ABW (10 days), but was significantly slower for those receiving <2x 10(6)/kg CD34+ cells/kg IBW (12 days). These data show that the CD34+ cell dose based on IBW is a better predictor of neutrophil recovery after autotransplantation.
引用
收藏
页码:861 / 864
页数:4
相关论文
共 13 条
[1]   PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION [J].
BENSINGER, WI ;
LONGIN, K ;
APPELBAUM, F ;
ROWLEY, S ;
WEAVER, C ;
LILLEBY, K ;
GOOLEY, T ;
LYNCH, M ;
HIGANO, T ;
KLARNET, J ;
CHAUNCEY, T ;
STORB, R ;
BUCKNER, CD .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :825-831
[2]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[3]   High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation [J].
Ketterer, N ;
Salles, G ;
Raba, M ;
Espinouse, D ;
Sonet, A ;
Tremisi, P ;
Dumontet, C ;
Moullet, I ;
Eljaafari-Corbin, A ;
Neidhardt-Berard, EM ;
Bouafia, F ;
Coiffier, B .
BLOOD, 1998, 91 (09) :3148-3155
[4]  
Mehta J, 1996, BONE MARROW TRANSPL, V18, P319
[5]   Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: An important modifiable factor influencing outcome [J].
Mehta, J ;
Powles, R ;
Treleaven, J ;
Kulkarni, S ;
Horton, C ;
Singhal, S .
BLOOD, 1997, 90 (09) :3808-3810
[6]  
Mehta J, 1996, BONE MARROW TRANSPL, V18, P741
[7]   Peripheral blood stem cells - Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells [J].
Mehta, J ;
Singhal, S ;
Gordon, L ;
Tallman, M ;
Williams, S ;
Luyun, R ;
Ali, MY ;
Oyama, Y ;
Villa, M ;
Shook, T ;
Winter, J .
BONE MARROW TRANSPLANTATION, 2002, 29 (07) :563-567
[8]   CD34+ cell collection efficiency does not correlate with the pre-leukapheresis hematocrit [J].
Mehta, J ;
Oyama, Y ;
Winter, J ;
Williams, S ;
Tallman, M ;
Singhal, S ;
Villa, M ;
Shook, T ;
Burt, R ;
Traynor, A ;
Soff, G ;
Masarik, S ;
Ramsey, G ;
Gordon, L .
BONE MARROW TRANSPLANTATION, 2001, 28 (06) :597-601
[9]  
Shpall E J, 1998, Biol Blood Marrow Transplant, V4, P84
[10]   Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation [J].
Singhal, S ;
Powles, R ;
Kulkarni, S ;
Treleaven, J ;
Sirohi, B ;
Millar, B ;
Shepherd, V ;
Saso, R ;
Rowland, A ;
Long, S ;
Cabral, S ;
Horton, C ;
Mehta, J .
BONE MARROW TRANSPLANTATION, 2000, 25 (05) :501-505